Zhongnan Medical Journal Press

Home Results

A total of 2367 result was found. Results that relate to M

Validation of virus inactivation/removal efficacy in production process of transfer factor solution

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1170-1177.
2067 times 516 times

XUE Meiling GUO Weizhen WANG Hongxin WANG Chuanli CHEN Meihong WEI Xiaoliang

Transfer factor solution Virus inactivation Virus removal Pasteurization Ultrafiltration membrane filtration method
Details
Assessment of the impact of continuous renal replacement therapy on imipenem pharmacokinetics and clinical efficacy in critically ill patients via therapeutic drug monitoring

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1178-1186.
2303 times 556 times

ZHANG Li CHEN Yuan HU Miao WAN Panting LIU Pingyu

Imipenem Continuous renal replacement therapy Therapeutic drug monitoring Pharmacokinetics/pharmacodynamics Individualized dosing
Details
Simultaneous determination of 4 anti-infective drug concentrations in human plasma by LC-MS/MS

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1187-1195.
2018 times 501 times

FU Yao QIAN Zhengyue AO Hui CAO Jianfeng LI Jing

Liquid chromatography-tandem mass spectrometry Plasma drug concentration Imipenem Meropenem Posaconazole Colistin E Therapeutic drug monitoring
Details
Identification of safety signals for antiepileptic drug-associated thrombocytopenia in minor population utilizing the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1196-1204.
2133 times 529 times

DUAN Difan CHEN Yan LIN Gaoyang QIAN Mengying SHAN Qing GUO Jinmin

Thrombocytopenia Antiepileptic drugs Minor population Food and Drug Administration Adverse Event Reporting System Adverse drug event Signal mining
Details
Data mining and risk profile construction of ravulizumab adverse events based on severity stratification

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1213-1222.
1897 times 464 times

OU Dan ZHOU Zhou

Ravulizumab Serious adverse events Data mining FAERS database
Details
Analysis of characteristics for SGLT2 inhibitor-associated Fournier gangrene based on the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1223-1229.
2029 times 456 times

TAN Wanli LI Dan YAO Huijuan

Sodium-glucose co-transporter 2 inhibitor Fournier gangrene Adverse drug reaction Data mining FDA Adverse Event Reporting System database
Details
Analysis of the current situation and development of the research onPeperomia dindygulensis based on bibliometrics

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1230-1237.
1951 times 565 times

WANG Heshan LI Qianhong XIE Zixin WANG Kaige LI Huang FAN Shiming WU Shuisheng

Peperomia dindygulensis Bibliometrics CiteSpace Visualization analysis Secolignans Peperomine Cluster analysis
Details
Research progress on the prevention and treatment of radiation-induced lung injury with medicinal and edible Chinese herbs

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1238-1249.
2083 times 526 times

ZHANG Xinling ZHANG Jiaxuan ZHANG Yu HOU Wenbin SHANG Haihua LI Yiliang

Medicinal and edible Chinese herbs Radiation-induced lung injury Prevention and treatment Radiation pneumonitis Radiation-induced pulmonary fibrosis Glycyrrhiza uralensis Angelica sinensis Astragalusmembranaceus
Details
Advances in nevirapine drug delivery systems

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1250-1255.
1897 times 440 times

REN Jinmei WANG Jing

Nevirapine Drug delivery system Nanotechnology Solid dispersion Targeted delivery Long-acting formulation
Details
A case report on the pharmacological management of post-liver transplantationCandida aurisbloodstream infection

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1256-1260.
1893 times 487 times

LAI Xiaomin CHEN Fanghui ZHANG Xiaojuan YU Hongxiu YANG Jian

Post-liver transplantation Candida auris Caspofungin Amphotericin B liposome Pharmaceutical care
Details
Association between air pollutants and the risk of medical visits for community-acquired pneumonia among children and adolescents in Tianmen: a time-series analysis of lagged effects

Published on New Medicine 2026,36(8):861-868.
1127 times 462 times

WANG Hongyong SONG Jiangqin LIAO Hongming

Community-acquired pneumonia Children Adolescents Air pollution Lagged effect Exposure-response relationship
Details
Study of the antitumor activity of MMSA-1 CAR-T cells in multiple myeloma

Published on New Medicine 2026,36(8):850-860.
1087 times 652 times

TONG Xiqin LIANG Yuxing CHEN Guopeng ZHOU Fuling

MMSA-1 CAR-T Immunotherapy Multiple myeloma Xenograft model
Details
Analysis of the results and influencing factors of the ESAT6-CFP10 skin test for close contacts of pulmonary tuberculosis patients in the school

Published on New Medicine 2026,36(8):869-875.
1257 times 399 times

QIU Yaoxue CHEN Cheng WU Danqing ZHOU Qing WANG Yu

Pulmonary tuberculosis School Close contacts ESAT6-CFP10 skin test Influencing factors
Details
Efficacy and safety of pyrotinib-based single-targeted versus dual-targeted therapy in HER2-positive stage Ⅳ breast cancer

Published on New Medicine 2026,36(8):876-883.
1069 times 370 times

ZHI Limin HUANG Lei PANG Xiaohong WU Qiong LEI Yu

Pyrotinib Human epidermal growth factor receptor 2 positive Stage Ⅳ breast cancer Efficacy Diarrhea
Details
Trends analysis and prediction of the HIV/AIDS disease burden in China from 1990 to 2023

Published on New Medicine 2026,36(8):884-891.
1610 times 597 times

WU Zhangjing CAO Wencong RONG Yi XIAO Chunmei YU Yong

HIV/AIDS Disease burden Mortality Disability-adjusted life years
Details